Health Care·Health Care Equipment·$45.0B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.98 | N/A | +5.80% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.98 | N/A | +5.80% |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Management expressed caution regarding market conditions and did not provide detailed guidance for the upcoming quarters. They are focused on managing costs and efficiency.
Management highlighted challenges in the current market environment.
They emphasized a focus on maintaining operational efficiency.
There were no specific growth initiatives discussed.
IDEXX Labs reported a better-than-expected EPS, which indicates some resilience in their earnings despite market challenges. However, the stock fell by 3.48%, likely due to the lack of revenue details and cautious management commentary. Investors may be concerned about future growth prospects without clear guidance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
VERIZON COMMUNICATIO
Jan 29, 2019